Oxford Nanopore Technologies Collaborates With Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine
New workflow to provide unambiguous genetic results in a single assay, alleviating the need for time-consuming and costly follow-up tests Oxford Nanopore Technologies (Oxford Nanopore) today announced
Gordon Sanghera Oxford Nanopore Technologie Emilym Leproust Oxford Nanopore Pharmacogenomics Pgx Beta Program Pharmacogenomics Beta Program
Source: finanznachrichten.de